Wave Life Sciences (WVE-007): Why Experts See Big Potential for Weight Loss
Experts rate WVE-007 a Buy. It promises effective, safe weight loss, improves sugar use, and might need less frequent shots.
/ 2 items
Experts rate WVE-007 a Buy. It promises effective, safe weight loss, improves sugar use, and might need less frequent shots.
Beam Therapeutics rallied after Wave Life Sciences' WVE-006 trial data for alpha-1 antitrypsin deficiency (AATD) fell below expectations.